Blockade of AT1R with telmisartan showed a comparative level of protection as seen in the liraglutide group, suggesting that these beneficial effects are associated with inhibition of AT1 receptor-mediated events in cardiac hypertrophy. The gene discussed is AGTR1; the disease is cardiac hypertrophy.